Company Filing History:
Years Active: 2010
Title: Søren Weis Dahl: Innovator in Dipeptidyl Peptidase I Research
Introduction
Søren Weis Dahl is a notable inventor based in Rungsted Kyst, Denmark. He has made significant contributions to the field of biochemistry, particularly in the study of dipeptidyl peptidase I (DPPI) proteins. His work has implications for the design of compounds that can interact with these proteins, which are crucial in various biological processes.
Latest Patents
Søren Weis Dahl holds a patent titled "Dipeptidyl peptidase I crystal structure and its uses." This invention focuses on the structural studies of DPPI proteins, including modified versions and their co-complexes. The patent details the crystal structure of DPPI obtained through X-ray crystallography from both rat and human sources. Furthermore, it outlines methods for utilizing the structural coordinates of DPPI and its mutants to design compounds that can bind to the active site or accessory binding sites, as well as to create improved inhibitors of DPPI.
Career Highlights
Throughout his career, Søren Weis Dahl has demonstrated a commitment to advancing scientific knowledge in his field. His patent represents a significant achievement, showcasing his expertise in structural biology and protein chemistry. His work has the potential to lead to new therapeutic approaches in treating diseases related to DPPI.
Collaborations
Søren has collaborated with notable colleagues, including Johan Olsen and Anders Kadziola. These partnerships have likely contributed to the depth and breadth of his research, enhancing the impact of his findings in the scientific community.
Conclusion
Søren Weis Dahl is a distinguished inventor whose work on dipeptidyl peptidase I has opened new avenues for research and potential therapeutic applications. His contributions to the field are invaluable and continue to influence ongoing studies in biochemistry.